In the years since thalidomide, we have added significantly to our list of known teratogens, but we are still unhappily ignorant about the degree of risk and mechanisms of teratogenesis. Thus, the physician faced with the concern of a pregnant patient confronts difficult dilemmas. Summarizing current knowledge, this presentation also suggests counseling guidelines.